AbCellera Biologics Inc. (ABCL) — QMA analysis
Sector: Healthcare · Market cap: $946M · Price: $11.82 · Data as of 2026-10-23
A composite score of 58/100 places AbCellera Biologics Inc. in the neutral band, higher score than 89% of 22,734 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Earnings quality.
What 12 data layers say about ABCL
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 43/100 |
| Earnings quality (EQS) | 15/100 |
| Technical trend (TSS) | 62/100 |
| Relative strength (RS) | 68/100 |
| Momentum (USS) | 41/100 |
| Insider activity (IAS) | 44/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 73/100 |
| Institutional 13F (IFS) | 59/100 |
| Options flow (OFS) | 81/100 |
| News sentiment (NSS) | 54/100 |
| Analysts / transcripts (ATS) | 86/100 |
| Catalysts (XS) | 76/100 |
What does the QMA model currently show for AbCellera Biologics Inc.?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For ABCL the layers diverge — some score high (Analysts / transcripts), others low (Earnings quality). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
ABCL insider & smart money activity
Over the recent period we record 4 reported insider purchases and 0 sales for ABCL: only reported purchases, no sales. A description of the data layer, not an instruction.
ABCL seasonality
The historically strong window for ABCL was July 1–28 with a hit rate of 67% and an average move of 5.3% (7 years of history).
Historical data does not guarantee future results.
How ABCL compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for ABCL stock?
58/100 (B) — Data as of 2026-10-23.
Are insiders buying ABCL stock?
Over the recent period, reported: purchases 4, sales 0 (purchases $1.55M). Insider activity: only reported purchases, no sales — a description of reported data, not a trade instruction.
Where can I see live ABCL data?
Live ABCL data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]